Gainers
- Artiva Biotherapeutics (NASDAQ:ARTV) shares increased by 96.8% to $5.45 during Thursday's after-market session. The company's market cap stands at $73.3 million.
- Akanda (NASDAQ:AKAN) shares increased by 62.33% to $3.62. The market value of their outstanding shares is at $1.7 million.
- Kezar Life Sciences (NASDAQ:KZR) shares increased by 45.93% to $6.1. The company's market cap stands at $31.4 million.
- Achieve Life Sciences (NASDAQ:ACHV) shares rose 29.87% to $4.0. The company's market cap stands at $162.5 million.
- Femasys (NASDAQ:FEMY) shares increased by 25.15% to $0.94. The company's market cap stands at $17.9 million.
- Disc Medicine (NASDAQ:IRON) stock rose 9.0% to $81.0. The market value of their outstanding shares is at $2.6 billion.
Losers
- INVO Fertility (NASDAQ:IVF) stock declined by 25.9% to $1.03 during Thursday's after-market session. The market value of their outstanding shares is at $3.2 million.
- WORK Medical Tech Gr (NASDAQ:WOK) shares declined by 24.28% to $0.04. The company's market cap stands at $4.5 million.
- NewGenIvf Group (NASDAQ:NIVF) shares fell 23.96% to $1.54. The market value of their outstanding shares is at $3.8 million.
- Genprex (NASDAQ:GNPX) stock declined by 12.06% to $0.42. The company's market cap stands at $36.0 million.
- Rallybio (NASDAQ:RLYB) stock fell 7.08% to $0.51. The company's market cap stands at $22.3 million.
- Enanta Pharma (NASDAQ:ENTA) stock fell 6.86% to $10.6. The company's market cap stands at $337.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AKANAkanda Corp
$2.22-3.02%
ARTVArtiva Biotherapeutics Inc
$5.55-7.65%
ENTAEnanta Pharmaceuticals Inc
$11.201.73%
FEMYFemasys Inc
$0.6700-4.71%
GNPXGenprex Inc
$0.3500-3.54%
IRONDisc Medicine Inc
$87.50-2.71%
IVFINVO Fertility Inc
$0.6946-7.61%
KZRKezar Life Sciences Inc
$6.33-0.47%
NIVFNewGenIvf Group Ltd
$1.240.81%
RLYBRallybio Corp
$0.5348-0.06%
WOKWORK Medical Technology Group Ltd
$0.0380-4.76%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.